These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 13865768)

  • 21. [Poliomyelitis vaccination. Value of a booster injection].
    MARTIN R; DAMAS JP
    Rev Med Fr; 1960 Jan; 41():27-32. PubMed ID: 24546182
    [No Abstract]   [Full Text] [Related]  

  • 22. [Viral excretion and antibody formation after use of a live trivalent poliomyelitis vaccine (Cox-Lederle)].
    ENDERS-RUCKLE G; SIEGERT R
    Dtsch Med Wochenschr; 1961 Oct; 86():1999-2008. PubMed ID: 13890174
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibody response to increased amounts of poliomyelitis vaccine.
    BARNETT EV; BARON S
    Am J Hyg; 1960 Jan; 71():59-68. PubMed ID: 13796911
    [No Abstract]   [Full Text] [Related]  

  • 24. Unpredictability of antibody response of infants to injections of Salk poliomyelitis vaccine.
    CRAMBLETT HG; FOMON SJ
    J Pediatr; 1961 Jun; 58():779-84. PubMed ID: 13696225
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antibody response to anti-poliomyelitis vaccine (Salk type) in a group of children in the first 4 years of life].
    ODDO FG; FLACCOMIO R; PRIOLO A; SANTAMAURA S
    Riv Ist Sieroter Ital; 1959; 34():225-35. PubMed ID: 14428254
    [No Abstract]   [Full Text] [Related]  

  • 26. The antibody response to poliomyelitis vaccine in school-children at the time of initial vaccination and one year later.
    ARMSTRONG CW; MOSS GW; POTTER FC
    Can J Public Health; 1957 Mar; 48(3):96-100. PubMed ID: 13413743
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibody response of newborns to formalinized poliomyelitis vaccine (Salk type).
    RANNON L; GOLDBLUM N; SKALSKA P; GOTLIEB A
    Am J Hyg; 1960 Sep; 72():244-9. PubMed ID: 13739498
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of booster inoculations on the serologic status of children vaccinated with poliomyelitis vaccine.
    BROWN GC
    Am J Public Health Nations Health; 1955 Nov; 45(11):1401-8. PubMed ID: 13258901
    [No Abstract]   [Full Text] [Related]  

  • 29. [Observations on the immunizing effect of small doses of poliomyelitis vaccine inoculated by intradermal route in adult subjects].
    ROSA A; LA PLACA M
    Riv Ital Ig; 1959; 19():143-8. PubMed ID: 14438768
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibody responses to British poliomyelitis vaccine of children with naturally occurring antibody.
    RUSSELL K
    Br Med J; 1958 Mar; 1(5071):622-4. PubMed ID: 13510748
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunization of infants with living attenuated poliomyelitis virus; laboratory investigations of alimentary infection and antibody response in infants under six months of age with congenitally acquired antibodies.
    FLACK A; HUMMELER K; HUNT AD; JERVIS GA; KOPROWSKI H; NORTON TW; STOKES J
    J Am Med Assoc; 1956 Dec; 162(14):1281-8. PubMed ID: 13366742
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antibody response of the infant to antipoliomyelitic vaccine].
    MORRONE G; NUNZIATA B; PICCIOTTO L; BRANCATO P
    Riv Ist Sieroter Ital; 1960; 35():590-602. PubMed ID: 13772898
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunogenicity, in children, of ultraviolet-treated poliomyelitis vaccine.
    WOLF AM; SHAUGHNESSY HJ; CHURCH RE; MILZER A; JANOTA M; OPPENHEIMER F; MORRISSEY RA; NAFTULIN H; CHAPMAN JW; LEVINSON SO
    J Am Med Assoc; 1956 Jun; 161(9):775-81. PubMed ID: 13319005
    [No Abstract]   [Full Text] [Related]  

  • 34. Response of infants to a third dose of poliomyelitis vaccine given 10 to 12 months after primary immunization.
    PERKINS FT; YETTS R; GAISFORD W
    Br Med J; 1959 Mar; 1(5123):680-2. PubMed ID: 13629087
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the antibody response to commercial anti-poliomyelitis vaccines used in Italy in the years 1957-1960].
    SANTOPADRE G; RUSCHI A; CASAROSA S; BENDINELLI M
    Riv Ist Sieroter Ital; 1962; 37():37-51. PubMed ID: 14497067
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunization against poliomyelitis with a trivalent oral vaccine.
    COX HR; CABASSO VJ; EMBIL J; MARKHAM FS; MOSES MJ; MOYER AW; ROCA-GARCIA M; RUEGSEGGER JM
    Pathol Microbiol (Basel); 1961; 24(Suppl)():61-72. PubMed ID: 13696125
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunization of infants with formalinized poliomyelitis vaccine (Salk type).
    SPIGLAND I; GOLDBLUM N
    Pediatrics; 1960 May; 25():812-21. PubMed ID: 13833339
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunogenicity of poliomyelitis vaccine prepared with ultraviolet irradiation and mild heat.
    SHAUGHNESSY HJ; WOLF AM; JANOTA M; NEAL J; OPPENHEIMER F; MILZER A; NAFTULIN H; MORRISSEY RA
    Proc Soc Exp Biol Med; 1957 Jun; 95(2):251-5. PubMed ID: 13441701
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of filtration procedures on immunogenic activity and safety of formalinized poliomyelitis vaccine (Salk type).
    GOLDBLUM N; MERCADO A; FOGEL A; CYMBALISTA S
    Proc Soc Exp Biol Med; 1959 Feb; 100(2):276-9. PubMed ID: 13634110
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunization of man against poliomyelitis with attenuated preparations of living virus.
    KOPROWSKI H
    Ann N Y Acad Sci; 1955 Sep; 61(4):1039-49. PubMed ID: 13340613
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.